Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PEER COMPARISON
Peer Comparison      
Jagsonpal Pharmaceuticals Ltd.
Peer CompaniesPrice(Rs)Chg(Rs) Chg(%)EPS(Rs.)TTM P/EVolume(000's)1Year Return(%)Divinded YieldBook Value
NGL Fine-Chem 3063.6 348.75 12.85 67.39 45.46 5135187.41 0.06 452.6
Neuland Laboratories 17177.5 225.25 1.33 283.01 60.69 97028.73 0.2 1182.3
Abbott India 26272.05 198.1 0.76 730.39 35.97 528-16.53 2.5 1978.48
Senores Pharmaceutic 1291.25 131.65 11.35 4.4 293.66 60079136.28 0 153.74
Kwality Pharma 2497 124.25 5.24 64.91 38.47 10821147.23 0 255.44
Procter&Gamble Healt 6273.55 85.85 1.39 196.94 31.85 4777.44 3.27 320.52
Venus Remedies 1801.25 84.8 4.94 74.3 24.24 22982306.14 0.56 441.01
Caplin Point Lab 2411.3 80.5 3.45 52.17 46.22 1155114.05 0.17 221.22
Strides Pharma Scien 1054.3 64.95 6.56 19.92 52.92 1765523.56 0.47 346.37
Orchid Pharma 917 64.55 7.57 8.91 102.88 3516126.97 0 261.06
Fredun Pharma 2310.75 61.2 2.72 60.24 38.36 9047189.06 0.03 483.87
Emcure Pharma 1734.25 51.65 3.07 38.65 44.88 281325.84 0.21 158.99
CORONA Remedies 1728.4 47.65 2.84 30.22 57.19 253  0.58 99.04
Supriya Lifescience 978.65 42.5 4.54 25.98 37.66 2687839.83 0.1 123.84
Sanofi Cons. Health 4629.1 42.25 0.92 111.98 41.34 114-8.95 1.62 166.96
Sai Life Sciences 1218.9 38.6 3.27 16.1 75.71 1677962.6 0 103.76
Eris Lifesciences 1402.9 36.15 2.64 17.61 79.65 4426-21.64 0.51 183.9
Jenburkt Pharma 1187.45 29.8 2.57 78.71 15.09 1743-7.37 1.74 389.23
Albert David 726.35 29.6 4.25 -2.62 0 632-15.26 0.69 687.7
Jubilant Pharmova 975.3 29.3 3.1 1.25 780.64 4743-13.34 0.51 144.98
Page 1 of 9 Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.